
Sign up to save your podcasts
Or


Dr. Jeff Burns discusses the amyloid hypothesis and the challenges clinicians face in navigating discussions on the use of aducanumab for Alzheimer disease with Dr. Erik Musiek.
By American Academy of Neurology4.7
283283 ratings
Dr. Jeff Burns discusses the amyloid hypothesis and the challenges clinicians face in navigating discussions on the use of aducanumab for Alzheimer disease with Dr. Erik Musiek.

320 Listeners

497 Listeners

51 Listeners

287 Listeners

3,341 Listeners

13 Listeners

1,153 Listeners

21 Listeners

194 Listeners

361 Listeners

513 Listeners

133 Listeners

180 Listeners

370 Listeners

79 Listeners